Tumor-derived PGE2 suppresses the activation of DCs by reducing IL-12 production, inhibiting co-stimulation and upregulating programmed death-ligand 1 (PD-L1) and arginase 1 (Arg1). This evidence concerns the gene ARG1 and neoplasm.